Guobang Pharma Ltd
SSE:605507
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guobang Pharma Ltd
SSE:605507
|
CN |
|
H
|
Huarchi Global Group Holdings Ltd
HKEX:2296
|
MO |
|
Biocept Inc
OTC:BIOCQ
|
US |
|
I
|
INNOX Advanced Materials Co Ltd
KOSDAQ:272290
|
KR |
|
N
|
Neosem Inc
KOSDAQ:253590
|
KR |
|
B
|
Buzzi SpA
SWB:UCM
|
IT |
|
Flutter Entertainment PLC
NYSE:FLUT
|
IE |
|
Atlas Critical Minerals Corp
NASDAQ:ATCX
|
BR |
|
Torrent Capital Ltd
XTSX:TORR
|
CA |
|
K
|
Kehua Holdings Co Ltd
SSE:603161
|
CN |
|
M
|
Magnificent Hotel Investments Ltd
HKEX:201
|
HK |
Bankruptcy Probability
Guobang Pharma Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Guobang Pharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
G
|
Guobang Pharma Ltd
SSE:605507
|
14.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Guobang Pharma Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Guobang Pharma Ltd has total debt of 920.1m CNY. This includes both short-term (441.4m CNY) and long-term (478.7m CNY) debt.
You can find a full breakdown on its Balance Sheet.
